Pfizer Gets FDA Approval for Expanded Use of Breast-Cancer Treatment Tukysa
Pfizer Inc PFECO
News
Vaxcyte Reports Bacterial-Infection Vaccine Met Primary Endpoints in Phase 3 Trial
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax — Update
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech
Pfizer on Pace for Largest Percent Increase Since November 2025 — Data Talk
Valneva Shares Climb After Lyme Disease Vaccine Receives EMA Application Acceptance
Pfizer Currently Up Eight Days Straight, On Pace for Longest Winning Streak Since April 2021 — Data Talk
Pfizer Logs Mixed 2Q on Oncology Growth, Covid-19 Declines
Pfizer's Litfulo Hits Endpoints in Nonsegmental Vitiligo Studies
Pfizer, BioNTech Updated Covid Vaccine Gets Europe Approval
Pfizer's Talzenna-Xtandi Combo Gets FDA Priority Review for Earlier-Stage Prostate Cancer
Arbutus Files More Patent Infringement Suits Against Pfizer, BioNTech — Update
Arbutus Files More Patent Infringement Suits Against Pfizer, BioNTech
Merck, Pfizer, Astellas Bladder Cancer Treatment Approved by FDA
Pfizer Gets FDA Approval for Breast Cancer Treatment
Nike Names Pfizer's Denton as Next CFO — Update
Nike Names Pfizer's Denton as Next CFO
Pfizer's Lung Cancer Drug Trial Misses Endpoint
Pfizer on Pace for Largest Percent Decrease Since September 2025 — Data Talk
Pfizer Chief Financial Officer Dave Denton to Leave — Update
United States